Literature DB >> 3887338

Imipramine in the treatment of panic disorder and its complications.

M R Liebowitz.   

Abstract

The recognition of the efficacy of imipramine for treating panic disorder and its complications has had major implications for clinical practice, diagnostic classification, theoretic understanding, and research strategies in the anxiety disorders. It has also resulted in benefit for a great number of affected individuals and promises to yield even greater relief of suffering as the findings become more widely disseminated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887338

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  4 in total

1.  Treating panic.

Authors:  P Tyrer
Journal:  BMJ       Date:  1989-01-28

Review 2.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 3.  Identifying patients at risk for, and treatment of major psychiatric complications of cancer.

Authors:  W Breitbart
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

Review 4.  Somatization in primary care: patients with unexplained and vexing medical complaints.

Authors:  C Kaplan; M Lipkin; G H Gordon
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.